Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470571 · ClinicalTrials.gov registry record
CMR Features in Patients With Suspected Myocarditis
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 670
- Enrollment target
NCT03470571: Completed study, sponsored by Brigham and Women's Hospital.
NCT03470571 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 670 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470571 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 670 participants
- Enrollment target
Study Summary
Presentation of myocarditis is heterogeneous, often ranges from being asymptomatic, to chest pain, dyspnoea, palpitations, and even sudden cardiac death. Diagnosing myocarditis is challenging with no current uniform clinical gold-standard. CMR is a key investigative tool, however the predictive value of CMR features is unknown. In this study we assess 670 consecutive patients with suspected myocarditis who were referred for CMR between 2002 and 2015 at the BWH. CMR features such as late gadolinium sizing, T1 mapping, extracellular volume fraction assessment, strain analysis (feature tracking), clinical data, labortory tetsings and electrocardiogramm are linked to the outcome in order to assess its predictive value.
Primary Outcome
Heart failure hospitalization; all cause death; sustained ventricular arrhythmia; recurrent myocarditis; transplantation
Interventions
- DIAGNOSTIC_TEST CMR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 670 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2018-02-01 |
What the finished NCT03470571 record still lists
NCT03470571 is an observational study that tracks outcomes without assigning an intervention. The registered 670 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CMR is the first listed.
NCT03470571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03470571 about?
NCT03470571 is a clinical study titled "CMR Features in Patients With Suspected Myocarditis". Presentation of myocarditis is heterogeneous, often ranges from being asymptomatic, to chest pain, dyspnoea, palpitations, and even sudden cardiac death. Diagnosing myocarditis is challenging with no current uniform clinical gold-standard. CMR is a key investigative tool, however the predictive valu...
What is the current status of trial NCT03470571?
This trial is currently completed. The enrollment target is 670 participants. The study started on 2016-06-01. Estimated completion is 2018-02-01.
What interventions are being tested in trial NCT03470571?
The interventions under investigation include: CMR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03470571?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- NCT05727904 · 670 participants · Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- NCT06223867 · 670 participants · NA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI